Acutus Medical

General Information


We are an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Despite several decades of efforts by incumbents in this field, the clinical and economic challenges associated with arrhythmia treatment continue to be a huge burden for patients, providers and payors. We are committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, we have established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products. Our goal is to provide our customers with a complete solution for catheter-based treatment of cardiac arrhythmias in each of our geographic markets.

Employees: 224
Founded: 2011
Contact Information
Address 2210 Faraday Ave., Suite 100, Carlsbad, CA 92008, US
Phone Number (442) 232-6080
Web Address
View Prospectus: Acutus Medical
Financial Information
Market Cap $469.9mil
Revenues $3.6 mil (last 12 months)
Net Income $-100.4 mil (last 12 months)
IPO Profile
Symbol AFIB
Exchange NASDAQ
Shares (millions): 8.8
Price range $18.00 - $18.00
Est. $ Volume $158.8 mil
Manager / Joint Managers J.P. Morgan/ BofA Securities/ William Blair
CO-Managers Canaccord Genuity/ BTIG
Expected To Trade: 8/6/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change